Search Results - Francesco Giorgino

Refine Results
  1. 1
    Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide

    Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide by Baptist Gallwitz, Francesco Giorgino

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future

    Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future by Irene Caruso, Francesco Giorgino

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials

    Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials by Francesco Giorgino, Anna Leonardini, Luigi Laviola

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?

    Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear? by Francesco Giorgino, Philip Home, Jaakko Tuomilehto

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

    Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Co... by Edoardo Mannucci, Alessandro Antenore, Francesco Giorgino, Marina Scavini

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk

    Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk by Francesco Giorgino, Jiten Vora, Peter Fenici, Anna Solini

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.

    Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. by Francesco Giorgino, Abdulraof Almahfouz, Laurie J. Goodyear, Robert J. Smith

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Cross‐Talk between PPAR<i>γ</i> and Insulin Signaling and Modulation of Insulin Sensitivity

    Cross‐Talk between PPAR<i>γ</i> and Insulin Signaling and Modulation of Insulin Sensitivity by Anna Leonardini, Luigi Laviola, Sebastio Perrini, Annalisa Natalicchio, Francesco Giorgino

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement

    Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement by Francesco Giorgino, A. Penfornis, V. Pechtner, R. Gentilella, Antonella Corcos

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    <scp>GLP</scp>‐1 receptor agonist added to insulin versus basal‐plus or basal‐bolus insulin therapy in type 2 diabetes: A systematic review and meta‐analysis

    <scp>GLP</scp>‐1 receptor agonist added to insulin versus basal‐plus or basal‐bolus insulin therapy in type 2 diabetes: A systematic review and meta‐analysis by Marco Castellana, Angelo Cignarelli, Francesco Brescia, Luigi Laviola, Francesco Giorgino

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program

    Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program by Johan Jendle, George Grunberger, Thomas Blevins, Francesco Giorgino, Ryan T. Hietpas, Fady T. Botros

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)

    Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2) by Francesco Giorgino, Marian Benroubi, Jui‐Hung Sun, Alan G. Zimmermann, V. Pechtner

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study

    Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study by Francesco Giorgino, Luigi Laviola, Paolo Cavallo Perin, Bogdan Solnica, J. Fuller, Nish Chaturvedi

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis

    The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis by Sebastio Perrini, Luigi Laviola, Marcos C. Carreira, Angelo Cignarelli, Annalisa Natalicchio, Francesco Giorgino

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Insulin and Insulin Receptors in Adipose Tissue Development

    Insulin and Insulin Receptors in Adipose Tissue Development by Angelo Cignarelli, Valentina Annamaria Genchi, Sebastio Perrini, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome

    Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome by Angelo Avogaro, Enzo Bonora, Agostino Consoli, Stefano Del Prato, Stefano Genovese, Francesco Giorgino

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Two Novel Proteins That Are Linked to Insulin-like Growth Factor (IGF-I) Receptors by the Grb10 Adapter and Modulate IGF-I Signaling

    Two Novel Proteins That Are Linked to Insulin-like Growth Factor (IGF-I) Receptors by the Grb10 Adapter and Modulate IGF-I Signaling by Barbara Giovannone, Eun-Hee Lee, Luigi Laviola, Francesco Giorgino, Kelly Cleveland, Robert J. Smith

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Effect of Family History of Type 2 Diabetes on the Intima-Media Thickness of the Common Carotid Artery in Normal-Weight, Overweight, and Obese Glucose-Tolerant Young Adults

    Effect of Family History of Type 2 Diabetes on the Intima-Media Thickness of the Common Carotid Artery in Normal-Weight, Overweight, and Obese Glucose-Tolerant Young Adults by Nicola Pannacciulli, Giovanni De Pergola, Marco Matteo Ciccone, P Rizzon, Francesco Giorgino, R Giorgino

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)

    GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET) by Raffaella Depalo, K Jayakrishan, Gabriella Garruti, Ilaria Totaro, Mariantonietta Panzarino, Francesco Giorgino, Luigi Selvaggi

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Performance of Five Ultrasound Risk Stratification Systems in Selecting Thyroid Nodules for FNA

    Performance of Five Ultrasound Risk Stratification Systems in Selecting Thyroid Nodules for FNA by Marco Castellana, Carlo Castellana, Giorgio Treglia, Francesco Giorgino, Luca Giovanella, Gilles Russ, Pierpaolo Trimboli

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: